Archive for 2007

CDEX’s Medical Patent Offers Industry Increased Security

It's hard to imagine a broader category for medical innovation than that of safety. CDEX has certainly made a big business of this, and maybe you can, too.

Dolly the Sheep Creators Secure New Medical Patent

The Rosilin Institute, which stunned the world when they cloned Dolly the Sheep, have secured additional cloning patents, as announced in Earth Times (December 11, 2007). This further strengthens their position in this field and has broad agriculture and medical implications. The new patents (U.S. Patent Nos. 7,304,204 and 7,307,198) cover methods of using differentiated cells to clone ungulate an... Read More

Organics Continues to Provide Patenting Opportunities

As these researchers, other scientists and medical practitioners, and entrepreneurs in areas far afield show us, organic solutions are solutions we can use and, in some cases, vitally need. Look into your own field of expertise--what uninvented organic solution might advance our bodies' abilities to develop and/or function? I, for one, would love to know, and, from what I've seen, the world would,... Read More

Announcing a Patented Remedy for Leukemia

Clinical trials have shown significant successes in halting a particular form of the disease known as Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) even into its most advanced stages. 1,100 newly diagnosed patients participated in the study with clinicians following their treatment throughout the course of the disease's progression.

Medical Patent Opportunity in “Skin Cell Therapy”?

Researchers at the Whitehead Institute of Biomedical Research in Massachussetts are conducting intense research to discover a safe way to turn skin cells into stem cells. Partly, this is to skirt around the ethics controversy surrounding the use of stem cells and partly it reflects the ready abundance of skin cells.